1. Therapy assessment of bone metastatic disease in the era of 223radium
   Elba Etchebehere et al, 2017, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
2. Prostate-specific membrane antigen radioligand therapy of prostate cancer
   Mohsen Beheshti et al, 2019, The Quarterly Journal of Nuclear Medicine and Molecular Imaging CrossRef
3. Dosimetry-Based Consideration on Remission and Relapse after Therapy with 223Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case Report
   Anna Mangano et al, 2018, Diagnostics CrossRef